Takeda Pharmaceutical (TAK) Short-term Investments: 2018-2025

Historic Short-term Investments for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $134.4 million.

  • Takeda Pharmaceutical's Short-term Investments rose 31.82% to $134.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $134.2 million, marking a year-over-year increase of 31.82%. This contributed to the annual value of $134.4 million for FY2025, which is 28.47% up from last year.
  • As of FY2025, Takeda Pharmaceutical's Short-term Investments stood at $134.4 million, which was up 28.47% from $104.6 million recorded in FY2024.
  • In the past 5 years, Takeda Pharmaceutical's Short-term Investments registered a high of $345.2 million during FY2021, and its lowest value of $104.6 million during FY2024.
  • For the 3-year period, Takeda Pharmaceutical's Short-term Investments averaged around $129.5 million, with its median value being $134.4 million (2025).
  • As far as peak fluctuations go, Takeda Pharmaceutical's Short-term Investments soared by 137.16% in 2021, and later plummeted by 34.71% in 2022.
  • Takeda Pharmaceutical's Short-term Investments (Yearly) stood at $345.2 million in 2021, then tumbled by 34.71% to $225.4 million in 2022, then crashed by 33.75% to $149.3 million in 2023, then dropped by 29.94% to $104.6 million in 2024, then rose by 28.47% to $134.4 million in 2025.